Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a platform of proprietary FASN inhibitors. For more information, please visit www.sagimet.com.
Company Details
- Employees
- 20
- Address
- 155 Bovet Rd,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- 3vbio.com
- Keywords
- in FASN biology and has created a platform of proprietary FASN inhibitors. For more information.
- HQ
- San Mateo, California
Sagimet Biosciences Questions
Sagimet Biosciences's website is 3vbio.com
Sagimet Biosciences's LinkedIn profile is https://www.linkedin.com/company/3-v-biosciences
Sagimet Biosciences has
20 employees.
View email and phone details for 20
employees at Sagimet Biosciences.
Sagimet Biosciences's industry is
Pharmaceutical Manufacturing
Sagimet Biosciences's top competitors are
Century Therapeutics, Inc,
Coherus Oncology,
Odyssey Therapeutics,
Apogee Therapeutics,
Avidity Biosciences, Inc.,
Mirum Pharmaceuticals, Inc.,
Latigo Biotherapeutics, Inc.,
Madrigal Pharmaceuticals,
Arrivent Biopharma,
Cour Pharma.
Sagimet Biosciences's categories are Pharmaceutical Manufacturing
